Table 3.

Time from diagnosis of pulmonary arterial hypertension to epoprostenol treatment for all subjects enrolled in the study.

Time from Diagnosis to TreatmentNo. of Subjects (%)
< 6 mo37 (36)
6 mo to 1 yr24 (23)
1 to 2 yrs23 (23)
2 to 5 yrs11 (11)
> 5 yrs7 (7)
Total number of subjects eligible to enroll102 (100)